Research Will Investigate If Vitamin E And Selenium Can Prevent
Prostate Cancer
Seattle
WA, 13 November 2003
On
Sunday, November 16, the nation's largest-ever prostate-cancer prevention
study, the Selenium and Vitamin E Cancer Prevention Trialor
SELECT for shortwill kick off a campaign, with the help of
black-community leaders and churches nationwide, to preach the importance
of participating in prostate-cancer-prevention research.
The
campaign, "SELECT Sunday," conducted in collaboration with the National
Black Leadership Initiative on Cancer II, seeks to double African-American
enrollment in SELECT, an international, National Cancer Institute-funded
study to determine whether vitamin E and the trace element selenium
can protect against prostate cancer, the most common form of malignancy
in men after non-melanoma skin cancer.
"Since
study recruitment began in the summer of 2001, we have enrolled
27,067 men and have met more than half of our recruitment goal,
but we still lack an adequate representation of African-American
men," said Russell Campbell, the study's national minority-recruitment
and adherence coordinator. "While more than 3,000 African-American
men already are participating in the study, our goal is to enroll
more than 6,000."
In
addition to boosting study enrollment, SELECT Sunday aims to raise
awareness of the seriousness of prostate cancer among African-American
men, who have the highest incidence rates in the world and a death
rate that's more than double that of white men, according to the
American Cancer Society.
Motivational
Speaker Les Brown Lends His Name to the Cause, Which Kicks Off Sunday
"Prostate
cancer is attacking our black men at an alarming rate and we need
to find a way to prevent this horrible disease," said the campaign's
celebrity supporter Les Brown, a motivational speaker, author and
television personality who also is a five-year survivor of prostate
cancer.
"Through
my involvement with SELECT Sunday, I encourage congregations nationwide
to host a SELECT Sunday service and to advise African Americans
about the importance of prostate-cancer awareness and participating
in SELECT. We need to help find a way to stop prostate cancer before
it starts."
SELECT Prevention
Study to Launch Awareness Campaign in Churches Nationwide
Starting
this weekend, participating churches are welcome to host SELECT
Sundays as often as they wish until study recruitment ends.
During
SELECT Sundays, pastors or other church officials will take about
five minutes from their regularly scheduled Sunday services to talk
about the importance of prostate-cancer awareness. Key messages
will include the fact that African-American men are at greater risk
and that the disease can be successfully treated when discovered
early.
Congregation
members will receive a flier about SELECT and a list of local study
sites. They also will receive handouts from the National Cancer
Institute about prostate-cancer risk factors, screening and early
detection. Men may be able to participate in SELECT if they are
55 or older (50 or older for black men); have had neither prostate
cancer nor any other type of cancer in the past five years (except
non-melanoma skin cancer); and are generally in good health.
SELECT,
a 12-year, $180 million study, ultimately will enroll 32,400 men
in the United States, Canada and Puerto Rico through a network of
400 research sites, many of which belong to a consortium of cancer-care
centers and physicians known as the Southwest Oncology Group, or
SWOG.
Fred
Hutchinson Cancer Research Center's Public Health Sciences Division,
along with Cancer Research and Biostatistics, or CRAB, another Seattle
nonprofit organization, houses the SWOG Statistical Center, which
designed the statistical structure of the study and will lead data
management and analysis for this massive international effort.
George
Counts, MD, a Fred Hutchinson physician and infectious-diseases
researcher with an extensive track record in breaking down barriers
in health-care disparity, sees the church partnership as positive
step toward bridging the enrollment gap.
"The
medical community needs to do a better job of educating minority
and underserved communities through their educational systems, churches,
news media and community leaders. SELECT Sunday is a great opportunity
for doing just that," said Counts, a member of Fred Hutchinson's
Clinical Research Division who serves as a senior adviser on special
populations for the HIV Vaccine Trials Network, a global effort
to develop and test a successful HIV vaccine.
"Participating
in medical research is beneficial to people of all racial backgrounds
and ethnicities. If African Americans don't participate in such
research we have no way of knowing whether certain medications or
prevention strategies will help themwhether the results can
be generalized to the population at large," Counts said.
Churches
that would like more information about hosting a SELECT Sunday or
men who would like more information about enrolling in the study
can contact the Cancer Information Service of the National Cancer
Institute at 1-800-4-CANCER or go to the Southwest
Oncology Group website (www.swog.org) and click on "SELECT"
and "How to Participate."
The
Fred Hutchinson Cancer Research Center, home of two Nobel laureates,
is an independent, nonprofit research institution dedicated to the
development and advancement of biomedical research to eliminate
cancer and other potentially fatal diseases. Fred Hutchinson receives
more funding from the National Institutes of Health than any other
independent U.S. research center. Recognized internationally for
its pioneering work in bone-marrow transplantation, the center's
four scientific divisions collaborate to form a unique environment
for conducting basic and applied science. Fred Hutchinson, in collaboration
with its clinical and research partners, the University of Washington
and Children's Hospital and Regional Medical Center, is the only
National Cancer Institute-designated comprehensive cancer center
in the Pacific Northwest and is one of 39 nationwide. For more information,
visit the Fred Hutchinson
Cancer Research Center website (www.fhcrc.org).
Advancing Knowledge,
Saving Lives
Cancer
Research and Biostatistics, or CRAB, is a nonprofit organization
whose purpose is to help conquer cancer and other diseases through
the application of biostatistical principles and data-management
methods. To learn more about CRAB, visit the Cancer
Research and Biostatistics website (www.crab.org).
Source
The
Fred Hutchinson Cancer Research Center.
|